This blog introduces a new series of blog posts that will look at interesting trends using the CMS’s historical Part D Star Ratings data, focusing on four measures of prescription drug adherence.
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on new National Health Expenditure (NHE) data from the Centers for Medicare & Medicaid Services: The latest NHE survey shows that the retail prescription drug net price index declined
Bass Explains Opposition to Legislation, Risk of Drug Companies Lowering Rx Discounts On Wednesday, expert witnesses testifying before the U.S. House Committee on Energy & Commerce Subcommittee on Health highlighted the critical value pharmacy benefit companies provide for patients, employers, and
The Independent Pharmacy Marketplace Is Stable Over the last ten years, the number of independent retail pharmacies nationwide increased by 1,719 stores, or 8%. Over the last five years, the marketplace for independent pharmacies has experienced small fluctuations from year-to-year,
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today issued 21 policy solutions supported by America’s pharmacy benefit managers (PBMs) aimed at reducing prescription drug costs for patients and health plan sponsors. PBMs administer prescription drug plans for more than 266 million Americans with
Pharmacy benefit companies are strong proponents of a highly functioning biosimilar market and have advocated for policy changes that will increase generic and biosimilar uptake and put an end to brand manufacturers’ tactics to extend exclusivity on brand-name biologics. As more
(Washington, D.C.) — Today, the U.S. House of Representatives passed the SUPPORT for Patients and Communities Act (H.R. 6), which will require electronic prescribing (e-prescribing) for controlled substances in Medicare. This is a significant step in the fight against America’s opioid
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott today issued the following statement supporting the policy of one-stop COVID-19 testing and treatment at pharmacies and calling on the Biden Administration to expand the scope of its
Katie Payne Senior Vice President, Public Affairs and Head of Advocacy Katie (Carr) Payne is Senior Vice President, Public Affairs and Head of Advocacy at PCMA. In this role, Katie is responsible for leading PCMA’s communications function and oversees the association’s
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today filed a lawsuit challenging the Trump Administration’s rebate rule. PCMA’s lawsuit, filed in the district court for the District of Columbia, asks the court to set aside the rebate rule
©2024 PCMA. All Rights Reserved.
